S100A8 and myeloid sarcoma: In MS, a disease that exclusively affects the CNS, patients had significantly higher serum levels of S100A8/A9 than healthy controls (medians 5150 ng/ml and 1482 ng/ml respectively), and MS patients with acute relapse had higher levels than MS patients with stable disease [18].